Genus Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	–	–	151
2024 Q2	–	Sell	-5,800	Closed	-$800K	–	153
2024 Q1	$800K	Buy	+5,800	New	+$800K	0.1%	146